FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

13756111000001101: Volibris 10mg tablets (GlaxoSmithKline) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2008. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
48994701000001114 Volibris 10mg tablets (GlaxoSmithKline) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
58174601000001119 Volibris 10mg tablets (GlaxoSmithKline UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Volibris 10mg tablets (GlaxoSmithKline) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Volibris 10mg tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Volibris 10mg tablets (GlaxoSmithKline) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Volibris 10mg tablets (GlaxoSmithKline) Is a Product containing precisely ambrisentan 10 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Volibris 10mg tablets (GlaxoSmithKline) Has active ingredient Ambrisentan false Inferred relationship Existential restriction modifier
Volibris 10mg tablets (GlaxoSmithKline) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Volibris 10mg tablets (GlaxoSmithKline) Has excipient Lactose false Inferred relationship Existential restriction modifier
Volibris 10mg tablets (GlaxoSmithKline) Is a Volibris true Inferred relationship Existential restriction modifier
Volibris 10mg tablets (GlaxoSmithKline) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Volibris 10mg tablets (GlaxoSmithKline) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Volibris 10mg tablets (GlaxoSmithKline) Has specific active ingredient Ambrisentan true Inferred relationship Existential restriction modifier
Volibris 10mg tablets (GlaxoSmithKline) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Volibris 10mg tablets (GlaxoSmithKline) Is a Actual medicinal product true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Volibris 10mg tablets (GlaxoSmithKline) 30 tablet 3 x 10 tablets Is pack of False Volibris 10mg tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier
Volibris 10mg tablets (GlaxoSmithKline) 30 tablet 3 x 10 tablets Has AMP True Volibris 10mg tablets (GlaxoSmithKline) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start